JPS5925684A - Stable p-hydroxybenzoic acid hydroxylase composition - Google Patents
Stable p-hydroxybenzoic acid hydroxylase compositionInfo
- Publication number
- JPS5925684A JPS5925684A JP13679082A JP13679082A JPS5925684A JP S5925684 A JPS5925684 A JP S5925684A JP 13679082 A JP13679082 A JP 13679082A JP 13679082 A JP13679082 A JP 13679082A JP S5925684 A JPS5925684 A JP S5925684A
- Authority
- JP
- Japan
- Prior art keywords
- hbh
- hydroxybenzoic acid
- salts
- enzyme
- flavine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010074633 Mixed Function Oxygenases Proteins 0.000 title claims abstract description 7
- 102000008109 Mixed Function Oxygenases Human genes 0.000 title claims abstract description 7
- 239000000203 mixture Substances 0.000 title claims description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 title abstract description 7
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- 235000000346 sugar Nutrition 0.000 claims abstract description 10
- 150000001413 amino acids Chemical class 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 8
- 229930024421 Adenine Natural products 0.000 claims description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 3
- 229960000643 adenine Drugs 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 abstract description 14
- 102000004190 Enzymes Human genes 0.000 abstract description 14
- 241000589516 Pseudomonas Species 0.000 abstract description 5
- 150000008163 sugars Chemical class 0.000 abstract description 3
- VWWQXMAJTJZDQX-UHFFFAOYSA-N Flavine adenine dinucleotide Natural products C1=NC2=C(N)N=CN=C2N1C(C(O)C1O)OC1COP(O)(=O)OP(O)(=O)OCC(O)C(O)C(O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UHFFFAOYSA-N 0.000 abstract 2
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 abstract 2
- 108010082309 4-hydroxybenzoate 3-monooxygenase Proteins 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- -1 galoctose Chemical compound 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010022470 Benzoate 1,2-dioxygenase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 101100156451 Mus musculus Vps33a gene Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000015870 tripotassium citrate Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明はパワーヒドロキシ安息香酸水酸化酵素(以下I
I B IIと略す)の安定化組成物に関する。さらに
詳しくはHBHKフフビンアデニンジヌクレメテド(以
下FADと略す)および/−またけ糖、糖アルコール、
アミノ酸またはその塩からなる群から選ばれた1種ある
いは2種以上の化合物を含有することにより、HBHを
安定化した試薬組成物である。DETAILED DESCRIPTION OF THE INVENTION The present invention provides power hydroxybenzoic acid hydroxylase (hereinafter referred to as I
I B II). More specifically, HBHK fufuvin adenine dinuclemeted (hereinafter abbreviated as FAD) and/-makase sugar, sugar alcohol,
This reagent composition stabilizes HBH by containing one or more compounds selected from the group consisting of amino acids or salts thereof.
ここで述べるII B Hはフラビン関与の外部電子供
与体要求性一原子酸素添加酵素に属するパワーヒドロキ
シベンゾエートヒドロキシラーゼ(fW%4番りE C
、1,14,13,2)の事である。この酵素は細菌、
特にシュードモナス属より得られている。The IIBH described here is a power hydroxybenzoate hydroxylase (fW% 4th grade E C
, 1, 14, 13, 2). This enzyme is bacteria,
It is especially obtained from the genus Pseudomonas.
文献ではシュードモナスデスモリティ力[Yano。In the literature, Pseudomonas desmolitii [Yano.
K、 + Higash i、 N−+ Ar ima
、 K、+ :Biochem、 Biophys、
Res。K, + Higash i, N-+ Arima
, K, + :Biochem, Biophys,
Res.
Co+nmun1341 (1969)) シュード
モナスフルメレツセ:y ス(I(owelL L、
G、+ 5pector+ i’、 、 R(asse
y+ V、 : J。Co+nmun1341 (1969)) Pseudomonas furmeretse:ysu(I(owelL L,
G, +5pector+i', , R(asse
y+V, :J.
Biol、Chem1247+ 4340 (1972
):]シュードモナスブチ ダ [)Iosokawa
+ K、、5tanier+ IもY、:J、Biol
、Chem、+241.2453 (1966))
などがある。Biol, Chem1247+4340 (1972
):] Pseudomonas buchida [)Iosokawa
+ K,, 5tanier + I also Y, :J, Biol
, Chem, +241.2453 (1966))
and so on.
この酵素の反応は以下の通りである。The reaction of this enzyme is as follows.
最近、臨床検査薬の分野でこの酵素を用いて血清=1リ
ンエステヲーゼを測定する測定用試薬の開発が期待され
ている。つまり従来のコリンエ不テラーゼは各測定法に
より測定値がまちまちで標準法がなくこの酵素を用いる
測定法が、この期待に応えるものと注目されている。Recently, in the field of clinical diagnostic reagents, there have been expectations for the development of a measuring reagent for measuring serum 1-phosphate esterase using this enzyme. In other words, the measurement values of conventional choline interase vary depending on the measurement method, and there is no standard method, so measurement methods using this enzyme are attracting attention as meeting these expectations.
この酵素はまた、酵素と基質複合体の形成、それに伴う
酵素結合FADのNADPHによる還元の活性化など興
味深い性質を示し、研究対象としても有用な酵素である
。したがって、これらのニュースに応えるために安定な
高純度の118 Hの提供が必要となってきた。This enzyme also exhibits interesting properties such as the formation of an enzyme-substrate complex and the accompanying activation of reduction of enzyme-bound FAD by NADPH, making it a useful enzyme for research. Therefore, in order to meet these news demands, it has become necessary to provide stable and highly purified 118H.
本発明者等はI(B Hの安定化剤について種々鋭意な
I究したところ本発明傾到達した。すなわち、本発明は
HB IIにFADおよび/または糖、糖アルコール、
アミノ酸またはその塩からなる群から選ばれた1種ある
いは2種以上の化合物を配合したことを特徴とする安定
なHI3 H組成物である。The present inventors have arrived at the present invention after conducting various intensive studies on stabilizers for HB II (HB II).That is, the present invention has been developed by combining FAD and/or sugar, sugar alcohol,
This is a stable HI3H composition characterized by containing one or more compounds selected from the group consisting of amino acids or salts thereof.
本発明において用いるFADの使用量はHBHiooo
単位当り0.001キ以上、好ましくけ0.1〜以上で
ある。上限は特に制限Vまないが経済的に考えて100
〜以下で充分である。The amount of FAD used in the present invention is HBHiooo
It is at least 0.001 kg per unit, preferably at least 0.1. There is no particular upper limit, but from an economic standpoint it is 100.
~ or less is sufficient.
本発明において用いる糖としては、ブドウ糖、果糖、ガ
ヲクトース、キシロース、リボース、リブロース等の単
糖類、シヨ糖、乳糖、マルトース等の二m類がある。特
にシヨ糖、乳糖が好寸しい。Sugars used in the present invention include monosaccharides such as glucose, fructose, galoctose, xylose, ribose, and ribulose, and diamoses such as sucrose, lactose, and maltose. Sugar and lactose are particularly good.
糖アルコールとしてハ、キシリトール、マンニトール、
ソルビトール等がある。特にマンニトールが好ましい。Sugar alcohols include xylitol, mannitol,
Sorbitol etc. Mannitol is particularly preferred.
アミノ酸又はその塩としてはグルタミン酸、アメパワギ
ン酸、グルタミン、アスバヲギン、リジン、ヒスチジン
、アルギニン、グリシン、γ−アミノ酪酸等の親水性テ
ミノ酸またはそのす) IJウム、カリウム、アンモニ
ウム等の塩または塩酸塩などがある。特にグルタミン酸
、アメパワギン酸またはその塩が好ましい。Examples of amino acids or their salts include hydrophilic temino acids and their salts such as glutamic acid, amepawagic acid, glutamine, asbawogin, lysine, histidine, arginine, glycine, and γ-aminobutyric acid; salts or hydrochlorides of IJum, potassium, ammonium, etc. There is. Particularly preferred are glutamic acid, amepawagic acid, or salts thereof.
糖1糖アルコール、アミノ酸またはその塩の16加量は
広範囲に選び得るがIIBH100O単位当り1〜10
00〜.好凍しくけ5〜100〜が適当である。The amount of sugar, monosaccharide alcohol, amino acid, or salt thereof can be selected from a wide range, but is between 1 and 10 per 1000 units of IIBH.
00~. A suitable freezing ratio is 5 to 100.
バフ・ハイドロキン安息香酸水酸化酵素の活性測定法は
以下の通りである。The method for measuring the activity of Buff Hydroquine benzoate hydroxylase is as follows.
トリス、マv−ト緩衝液 50mM pH8
,2バラ・ハイドロキシ安息香酸 0.5mMNAD
PHO,3mM
FAD O,02mMの反
応液3.0m1(37℃)に酵素希釈液50μ!を添加
し+340nmにおける吸光度の減少を測定する。1分
間当りlμtnoleのN A D P Hを変化させ
る酵素量を1単位とする。(N A D P Hの分子
吸光係数6.226A/micromole )本発明
の安定化剤の配合法は特に制限はない。Tris, Mat buffer 50mM pH8
, 2 rose hydroxybenzoic acid 0.5mMNAD
PHO, 3mM FAD O, 02mM reaction solution 3.0ml (37℃) and enzyme dilution solution 50μ! is added and the decrease in absorbance at +340 nm is measured. The amount of enzyme that changes the NADPH of lμtnole per minute is defined as 1 unit. (Molecular extinction coefficient of N A D P H 6.226 A/micromole) There is no particular restriction on the method of blending the stabilizer of the present invention.
例えばII B Hを含むa荷液に安定化剤を配合する
方法、安定化剤を含む緩衝液にHB Hを配合する方法
、あるいはHB Hと安定化剤を緩衝液に同時に配合す
る方法などがある。緩衝液としてはリン酸緩衝液、トリ
ス緩衝液その他生化学で用いられる緩衝液なら何れでも
良い。For example, there are methods such as adding a stabilizer to a cargo solution containing II B H, adding HB H to a buffer solution containing a stabilizer, or adding HB H and a stabilizer to a buffer solution at the same time. be. The buffer may be phosphate buffer, Tris buffer, or any other buffer used in biochemistry.
本発明ではFADおよび/または糖、糖アルコールまた
はその塩からなる群から選ばれた1種あるいは2種以上
の化合物を配合することにより。In the present invention, one or more compounds selected from the group consisting of FAD and/or sugar, sugar alcohol, or a salt thereof are blended.
無添加の場合に比べて酵素の安定性、特に凍結乾燥後の
酵素安定性が著しく向上する。また、凍結乾燥後の外観
は一段と優れたものとなる。さらに本発明の安定化剤は
他の化合物(グルコン酸カリウム、クエン酸三カリウム
)では酵素が安定化されても吸湿性が著しく助長される
に対して、吸湿性は変化しないかあるいけ改良される。Enzyme stability, especially enzyme stability after freeze-drying, is significantly improved compared to the case without additives. Moreover, the appearance after freeze-drying becomes even more excellent. Furthermore, with the stabilizer of the present invention, hygroscopicity is significantly promoted even if the enzyme is stabilized using other compounds (potassium gluconate, tripotassium citrate), whereas hygroscopicity remains unchanged or is improved. Ru.
本発明の安定化剤としては、糖、糖アルコール、アミノ
酸またはその塩からなる群から選ばれた化合物とFAD
とを併用すると、長期安定化が行われる。The stabilizer of the present invention includes a compound selected from the group consisting of sugar, sugar alcohol, amino acid or salt thereof, and FAD.
When used in combination, long-term stabilization is achieved.
以下1本発明を突施例を用いて説明する。The present invention will be explained below using a specific example.
リン酸緩衝液 50mM pH6,0各安定化
剤 10〜/ls1以上
の組成を調製し、各2耐づつ凍結乾燥を行った。凍結乾
燥後再び蒸留水2 wlを1ハ加し、残存活性を測定し
た。結果を表IK示す。Phosphate buffer 50mM pH 6.0 Each stabilizer 10~/ls1 or more compositions were prepared and freeze-dried in duplicate. After freeze-drying, 2 wl of distilled water was added once again, and the residual activity was measured. The results are shown in Table IK.
表1 (φ印は比較例を示す。)
実施例2゜
実施例1と同様の操作を行ない、凍結乾燥後45℃にお
ける温度安定性を検討した。結果を表2に示す。Table 1 (The φ mark indicates a comparative example.) Example 2 The same operation as in Example 1 was carried out to examine the temperature stability at 45° C. after freeze-drying. The results are shown in Table 2.
表2 45℃における残存活性(%)
バラ・ハイドロキシ安息香酸水酸化酵素 20〜/
解tフヲビンアデニンジヌクレオチド(FAD) 0
.1〜/1glリン酸緩衝液 50mM pH
6,0各安定化剤 1
0〜/yx1以上の組成を調製し、各2 mlづつ凍結
乾燥を行った。凍結乾燥後45℃における温度安定性を
検討した。結果を表3に示す。Table 2 Residual activity (%) at 45°C Rose hydroxybenzoic acid hydroxylase 20~/
Solution: Fiobin adenine dinucleotide (FAD) 0
.. 1~/1gl phosphate buffer 50mM pH
6.0 each stabilizer 1
Compositions of 0 to /yx1 or more were prepared and 2 ml of each was freeze-dried. After freeze-drying, temperature stability at 45°C was examined. The results are shown in Table 3.
表3 特許出願人 東洋紡績株式会社Table 3 Patent applicant: Toyobo Co., Ltd.
Claims (1)
糖アルコール、アミノ酸またはその塩からなる群から選
ばれた1種あるいは2種以上の化合物を配合したことを
特徴とする安定なバラ−ヒドロキシ安息香酸水酸化酵素
組成物。[Claims] Buff-hydroxybenzoic acid hydroxylase. fibrobin adenine dinucleotide and/or sugar,
A stable rose-hydroxybenzoic acid hydroxylase composition comprising one or more compounds selected from the group consisting of sugar alcohols, amino acids, or salts thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13679082A JPS5925684A (en) | 1982-08-04 | 1982-08-04 | Stable p-hydroxybenzoic acid hydroxylase composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13679082A JPS5925684A (en) | 1982-08-04 | 1982-08-04 | Stable p-hydroxybenzoic acid hydroxylase composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5925684A true JPS5925684A (en) | 1984-02-09 |
Family
ID=15183573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13679082A Pending JPS5925684A (en) | 1982-08-04 | 1982-08-04 | Stable p-hydroxybenzoic acid hydroxylase composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5925684A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63283579A (en) * | 1986-11-19 | 1988-11-21 | ジェネンコア インコーポレーテッド | Novel hydrogenase and its production |
JP2008206491A (en) * | 2007-02-28 | 2008-09-11 | Toyobo Co Ltd | METHOD FOR STABILIZING p-HYDROXYBENZOATE HYDROXYLASE |
US20090320982A1 (en) * | 2006-08-03 | 2009-12-31 | Bridgestone Corporation | Pneumatic tire |
EP1574363B1 (en) * | 2002-12-02 | 2011-01-12 | Sumitomo Rubber Industries, Ltd. | Tire with rotation period indication hole |
US8047244B2 (en) * | 2006-08-24 | 2011-11-01 | Sumitomo Rubber Industries, Ltd. | Pneumatic tire with tread having radially extending fine grooves |
US20180326795A1 (en) * | 2017-05-15 | 2018-11-15 | The Goodyear Tire & Rubber Company | Tread wear indicator |
US11413907B2 (en) | 2020-10-16 | 2022-08-16 | The Goodyear Tire & Rubber Company | Tire with shallow groove-based tread wear indicator |
-
1982
- 1982-08-04 JP JP13679082A patent/JPS5925684A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63283579A (en) * | 1986-11-19 | 1988-11-21 | ジェネンコア インコーポレーテッド | Novel hydrogenase and its production |
EP1574363B1 (en) * | 2002-12-02 | 2011-01-12 | Sumitomo Rubber Industries, Ltd. | Tire with rotation period indication hole |
US20090320982A1 (en) * | 2006-08-03 | 2009-12-31 | Bridgestone Corporation | Pneumatic tire |
US8708009B2 (en) * | 2006-08-03 | 2014-04-29 | Bridgestone Corporation | Pneumatic tire |
US8047244B2 (en) * | 2006-08-24 | 2011-11-01 | Sumitomo Rubber Industries, Ltd. | Pneumatic tire with tread having radially extending fine grooves |
JP2008206491A (en) * | 2007-02-28 | 2008-09-11 | Toyobo Co Ltd | METHOD FOR STABILIZING p-HYDROXYBENZOATE HYDROXYLASE |
US20180326795A1 (en) * | 2017-05-15 | 2018-11-15 | The Goodyear Tire & Rubber Company | Tread wear indicator |
US11413907B2 (en) | 2020-10-16 | 2022-08-16 | The Goodyear Tire & Rubber Company | Tire with shallow groove-based tread wear indicator |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Horowitz et al. | Glutamine-dependent asparagine synthetase from leukemia cells: chloride DEPENDENCE, MECHANISM OF ACTION, AND INHIBITION | |
Hess et al. | The Cytochemical Localization of Oxidative Enzymes: II. Pyridine Nucleotide-Linked Dehydrogenases | |
JP3219181B2 (en) | Stabilization method of cholesterol oxidase | |
Fishbein et al. | Purification and Properties of an Enzyme in Human Blood and Rat Liver Microsomes Catalyzing the Formation and Hydrolysis of γ-Lactones: I. TISSUE LOCALIZATION, STOICHIOMETRY, SPECIFICITY, DISTINCTION FROM ESTERASE | |
JP3125610B2 (en) | Method for stabilizing L-methionine γ-lyase | |
JPS5925684A (en) | Stable p-hydroxybenzoic acid hydroxylase composition | |
JPS5534001A (en) | Stabilization of sarcosine oxidase | |
Wilson et al. | The b-Glucoside System of Escherichia coli: IV. PURIFICATION AND PROPERTIES OF PHOSPHO-b-GLUCOSIDASES A AND B | |
del Campo et al. | Transport of α-methyl glucoside in mutants of Escherichia coli K12 deficient in Ca2+, Mg2+-activated adenosine triphosphatase | |
JP4847775B2 (en) | Stable polyol dehydrogenase composition | |
SEKUZU et al. | DENATURATION AND INACTIVATION OF ENZYME PROTEINS VII. EFFECT OF COENZYME AND SUBSTRATES ON DENATURA-TION OF DEHYDROGENASES | |
EP0009781B1 (en) | Process for the purification of long-chain acyl-coenzyme-a synthetase and the enzyme, acyl-coa synthetase, purified thereby | |
US5506113A (en) | Measuring composition | |
Koide et al. | Conformation of NAD+ bound to allosteric L-lactate dehydrogenase activated by chemical modification | |
Bueding et al. | Glucosamine kinase of Schistosoma mansoni | |
US3819487A (en) | Stable nadh compositions | |
Reinhart | Influence of fructose 2, 6-bisphosphate on the aggregation properties of rat liver phosphofructokinase. | |
FREIST et al. | Threonyl‐tRNA, Lysyl‐tRNA and Arginyl‐tRNA Synthetases from Baker's Yeast: Substrate Specificity with Regard to ATP Analogues | |
US5716797A (en) | Stable two-part reagent for the measurement of creatine kinase activity | |
Waheed et al. | Covalent modification as the cause of the anomalous kinetics of aryl sulfatase A | |
JPH07236483A (en) | Stabilization of physiologically active protein | |
US6884416B2 (en) | Stable PQQ-dependent glucose dehydrogenase composition | |
JP2008206491A (en) | METHOD FOR STABILIZING p-HYDROXYBENZOATE HYDROXYLASE | |
Schachter et al. | Product inhibition in the glycine N-acylase reaction | |
NIEUWENHUIS et al. | Solubilization by Cholate or Deoxycholate of a Dicyclohexylcarbodi-imide-Sensitive Adenosine Triphosphatase Complex from Escherichia coli |